THOMPSON DAVIS & CO., INC. - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 26 filers reported holding GEMPHIRE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$3,0002500.01%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders